Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Indivior Pharmaceuticals Inc. Common Stock (INDV) vs Wolfspeed Inc (WOLF) Price & Performance

Indivior Pharmaceuticals Inc. Common StockTrade
Wolfspeed IncTrade

Price performance (Past 24H)

Key statistics

Indivior Pharmaceuticals Inc. Common Stock vs Wolfspeed Inc — how do they compare? Indivior Pharmaceuticals Inc. Common Stock trades at $34.01 (market cap $4.18B), while Wolfspeed Inc trades at $23.79 (market cap $1.51B). The key difference: Indivior Pharmaceuticals Inc. Common Stock is far larger — about 2.8× Wolfspeed Inc's market cap, and Indivior Pharmaceuticals Inc. Common Stock is trading nearer its 52-week high, Wolfspeed Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Indivior Pharmaceuticals Inc. Common Stock for 0 Days and Wolfspeed Inc for 20 Days on average.

INDVWOLF
Market Cap
$4.18B$1.51B
Volume
1,819,7463,682,639
Sector
HealthTechnology
52-Week High
$41.83$73.68
52-Week Low
$24.09$14.80
Typical Hold Time
0 Days20 Days
Enterprise Value
$4.47B$2.22B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Indivior Pharmaceuticals Inc. Common Stock

No Aura AI signal available yet.

Wolfspeed Inc

Wolfspeed (WOLF) trades at $28.67, up 2.25% today, amid mixed technical signals with a bearish moving average trend but bullish oscillators. The company shows severe financial strain with negative gross margins of -16.05% and net losses of -$1.61B in 2025, though 2026 projects a return to profitability. Recent news highlights expansion of 200mm silicon carbide technology and ongoing investor litigation investigations.

The stock presents high-risk speculative potential with analyst consensus target of $54.32 suggesting significant upside, but requires successful execution on revenue growth and margin improvement. Key risks include persistent negative profitability, high debt burden, and competitive pressures in the semiconductor materials sector.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

INDV
100% Buy0% Sell
Avg holding period · 0 Days
WOLF
59% Buy41% Sell
Avg holding period · 20 Days

Top news

Latest headlines on both assets

About Indivior Pharmaceuticals Inc. Common Stock

Indivior Pharmaceuticals, Inc. is a pharmaceutical company focused on treatments for opioid use disorder and other addiction-related conditions, including its Suboxone film and tablet products.

Read more on INDV →

About Wolfspeed Inc

Wolfspeed is the global leader in wide bandgap semiconductors, specializing in silicon carbide (SiC) and gallium nitride (GaN) materials and devices. It operates a vertically integrated model, controlling the entire process from raw material substrate production to advanced power modules, serving as a critical infrastructure provider for electric vehicles (EVs), renewable energy, and AI data centers.

Read more on WOLF →